Sign in
WithdrawnNo phase

Adolescent PCIP Randomized Feasibility Trial

Key facts

Who runs it
University of California, Los Angeles
Where
Los Angeles, United StatesSee the site
Trial code
Status
Withdrawn
Started
3 Jan 2022
Ended
20 Dec 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Primary Care Intervention for PTSD (PCIP)
  • Treatment As Usual
Record updated
27 February 2026
Why it stopped
The study site preferred to conduct a non-randomized QI project

Who can take part

Age
12 years to 22 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Patient referred to the SHARK Program
  • Patients must be at least 12 years old
  • Screened for probable PTSD on UCLA RI, or at provider discretion of clinical relevancy
  • If patient is under 18 years old, the patient's legal guardian is able and willing to provide informed consent for the patient to participate in the study
  • Patient is able to complete study activities in English

Who cannot take part

  • Suicidal ideation with a plan within the last two weeks or a suicide attempt within the past 30 days
  • Inability to provide informed consent or assent, and/or complete procedures in English

Where in United States

  • University of California, Los AngelesLos Angeles, United States

About the trial

What the trial wants to find out

There are three research questions: (1) whether the Primary Care Intervention for PTSD (PCIP) improves health outcomes; (2) whether and how the PCIP can be sustainably delivered via telehealth; and (3) how PCIP compares to treatment as usual (TAU) participants.

Read full original descriptionShow less

The mixed methods randomized feasibility trial of the protocol will be measured by the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, Maintenance) (n=44 patients and their care givers). We will collect data on patient, caregiver, and clinic staff participation, retention, and satisfaction (Reach and Adoption), change in hypothesized treatment mechanisms and symptoms (Effectiveness), and facilitators and barriers to intervention delivery and fidelity (Implementation). We will,

1. Assess the reach and adoption of the protocol by analyzing quantitative data on patient and clinic staff participation, retention, and satisfaction; 2. Explore the effectiveness of the protocol through medical record review, quantitative assessments at baseline and post-treatment, and semi-structured qualitative interviews at baseline and post-treatment to: 3. Evaluate the implementation of the screening and intervention protocol with post-intervention semi-structured qualitative interviews to assess facilitators and barriers to intervention delivery, quantitative fidelity scales, observation of screening, and review of intervention audio recordings to assess fidelity to the protocol and intervention process.

The 2 groups in the trial

  • BREATHE Primary Care Intervention for PTSD (PCIP)Treatment being tested

    BREATHE PCIP is a treatment for Post-Traumatic Stress Disorder (PTSD) symptoms for use with individuals who have a diagnosis of PTSD or "probable PTSD." The treatment will be considered delivered when patients have learned and practiced breathing retraining and have discussed the symptoms of PTSD (Sessions 1 through 3).

    Treatment: Primary Care Intervention for PTSD (PCIP)

  • Treatment As UsualExisting treatment, for comparison

    Receive standard care treatment and provided information on free or low cost mental health care referrals in the Los Angeles Area.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Adolescent BREATHE Primary Care Intervention for PTSD (PCIP) Randomized Feasibility Trial
Record updated
27 February 2026